Sps Nephroplus Dialysis Private Limited - Company Profile

It is a professional services private limited company based in Hyderabad, Telangana, India, established in 2015.
2015 Hyderabad, Telangana, India Struck Off
Last Updated:
About Sps Nephroplus Dialysis Private Limited

Sps Nephroplus Dialysis Private Limited, a struck off private limited company, was established on 24 November 2015 in Hyderabad, Telangana, India. Engaging in book keeping within the professional services sector, it holds CIN: U74120TG2015PTC101904. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.45 M and a paid-up capital of ₹0.25 M.

Formerly known as Docity Health Services Private Limited. Its leadership includes Sandeep Gudibanda (Additional Director), Divya Kalva (Director). Past directors included Shivarudraswami Neelakanthamath. It is based at 10-2-289/120/202, Royal Home Siena Grandapartments Vijayanagar Colony, Masab Tank, Hyderabad, Telangana, 500025.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120TG2015PTC101904

  • Registration Number

    101904

  • Incorporation Date

    24 November 2015

  • Authorized Capital

    ₹0.45 M

  • Paid-Up Capital

    ₹0.25 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.45 M
  • Paid Up Capital ₹ 0.25 M
  • Company Age 10 Year, 2 Months
Company report

Sps Nephroplus Dialysis Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sps Nephroplus Dialysis Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sps Nephroplus Dialysis Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandeep Gudibanda Additional Director 12 May 2016 Current
Divya Kalva Director 24 Nov 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 12 May 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sps Nephroplus Dialysis.

Enhance accessibility to Sps Nephroplus Dialysis's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sps Nephroplus Dialysis revenue growth over time
Sps Nephroplus Dialysis profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sps Nephroplus Dialysis?

Unlock access to Sps Nephroplus Dialysis's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sps Nephroplus Dialysis?

Unlock and access historical data on people associated with Sps Nephroplus Dialysis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sps Nephroplus Dialysis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sps Nephroplus Dialysis's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sps Nephroplus Dialysis
Recent Activity within the Organization
  • Director Appointment

    Progress on Sandeep Gudibanda was appointed as a Additional Director was appointed as a Additional Director on 12 May 2016 & has been associated with this company since 9 years 9 months . was documented.

  • Director Appointment

    Divya Kalva was appointed as a Director was appointed as a Director on 24 Nov 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Sps Nephroplus Dialysis Private Limited was registered on 24 Nov 2015 with Roc Hyderabad & aged 10 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sps Nephroplus Dialysis Private Limited?

The CIN of Sps Nephroplus Dialysis Private Limited is U74120TG2015PTC101904.

Where is Sps Nephroplus Dialysis Private Limited headquartered?

Sps Nephroplus Dialysis Private Limited is headquartered at 10-2-289/120/202, Royal Home Siena Grandapartments Vijayanagar Colony, Masab Tank, Hyderabad, Telangana, 500025.

When was Sps Nephroplus Dialysis Private Limited incorporated?

Sps Nephroplus Dialysis Private Limited was incorporated on 24 November 2015.

Who are the current directors of Sps Nephroplus Dialysis Private Limited?

The current directors of Sps Nephroplus Dialysis Private Limited are

What is the primary industry of Sps Nephroplus Dialysis Private Limited?

The primary industry of Sps Nephroplus Dialysis Private Limited is Professional Services.

Is Sps Nephroplus Dialysis Private Limited a listed company?

Sps Nephroplus Dialysis Private Limited is unlisted.

What is the capital structure of Sps Nephroplus Dialysis Private Limited?

The authorized capital of Sps Nephroplus Dialysis Private Limited is ₹0.45 M, and the paid-up capital is ₹0.25 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available